Global Biologic Therapeutics Drugs Market Size, Share and Forecast 2021-2027
The global biologic therapeutics drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). The major factors contributing to the growth of the market include the rising prevalence of chronic disorders, including cancer, diabetes, and CVD. According to the World Health Organization (WHO), in 2020, the new cancer incidences reported was 19.3 million. Breast cancer was the most common cancer type in 2020 with almost 2.3 million cases, followed by lung cancer with 2.2 million cases, colon and rectum cancer with 1.9 million cases, prostate cancer with 1.4 million cases, and stomach cancer with 1.1 million cases.
To Request a Sample of our Report on Global Biologic Therapeutics Drugs Market: https://www.omrglobal.com/request-sample/biologic-therapeutics-drugs-market
Additionally, the increase in the geriatric population is propelling the
growth of the market. According to the World Population Prospects 2019, by
United Nation Population Division, approximately 9.3% of the total population
in 2019 was over 65 years of age. Moreover, the demand for innovative and
advanced R&D approaches for the treatment of chronic diseases will boost
the growth of the market. The rising geriatric population base is leading to an
increased incidence of rheumatoid arthritis, which in turn, is accelerating the
market growth.
Biological therapeutics is a field of research concerned with the development of medications and pharmaceutical products having biological origins. This field encompasses all pharmaceutical medication products made from semi-synthesized and biological sources. For rheumatoid arthritis, biological therapy targets the parts of the immune system that are triggering inflammation that causes joint and tissue damage. Some commonly used biological agents for the treatment of rheumatoid arthritis include SIMPONI ARIA (golimumab), REMICADE (infliximab), ACTEMRA (tocilizumab), ORENCIA (abatacept), RITUXAN (rituximab), and CIMZIA (certolizumab pegol). Some pipeline drugs have been witnessed, which is driving the market growth. For instance, in March 2021, Bicara Therapeutics launched a pipeline of dual-action biologics for cancer immunotherapy with a $40 million investment from Biocon Ltd. These pipeline drugs is offering an opportunity for market growth.
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Product
·
By
Application
·
Competitive Landscape- Pfizer Inc., AstraZeneca Plc, Novartis
International AG, Merck & Co., Inc, and GlaxoSmithKline Plc.
Key questions
addressed by the report
·
What is the market growth rate?
·
Which segment and region dominates the market in base year?
·
Which segment and region will project fastest growth in the market?
·
How COVID-19 impacted the market?
·
Recovery
Timeline
·
Deviation
from pre-COVID forecast
·
Most
affected region and segment
·
Who is the leader in the market?
·
How players are addressing challenges to sustain growth?
·
Where is the investment opportunity?
A
full Report of Global Biologic Therapeutics Drugs Market is Available
at: https://www.omrglobal.com/industry-reports/biologic-therapeutics-drugs-market
Global Biologic Therapeutics Market -
Segmentation
By Product
·
Blood and
Blood Products
·
Vaccines
·
Human
Cells and Tissues
·
Cellular
Therapies
·
Allergenic
Extracts
·
Gene
Therapies
·
Others
By Application
·
Rheumatoid
Arthritis
·
Anemia
·
Cancer
·
Diabetes
·
Others
Global
Biologic Therapeutics Market - Segmentation by Region
North
America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the
World
Reasons to buy from us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/biologic-therapeutics-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment